Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stem Cell Research

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    March 2023
  1. CARVALHO T
    Stem cell-derived heart cells injected into first patient.
    Nat Med. 2023 Mar 13. doi: 10.1038/d41591-023-00027.
    PubMed    


    February 2023

  2. HIV-1 cure after CCR5Delta32/Delta32 allogeneic hematopoietic stem cell transplantation.
    Nat Med. 2023 Feb 27. doi: 10.1038/s41591-023-02215.
    PubMed    


  3. JENSEN BO, Knops E, Cords L, Lubke N, et al
    In-depth virological and immunological characterization of HIV-1 cure after CCR5Delta32/Delta32 allogeneic hematopoietic stem cell transplantation.
    Nat Med. 2023 Feb 20. doi: 10.1038/s41591-023-02213.
    PubMed     Abstract available


    January 2023
  4. FOSSATI V, Peruzzotti-Jametti L, Pluchino S
    A neural stem-cell treatment for progressive multiple sclerosis.
    Nat Med. 2023 Jan 13. doi: 10.1038/s41591-022-02164.
    PubMed    


  5. GENCHI A, Brambilla E, Sangalli F, Radaelli M, et al
    Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.
    Nat Med. 2023 Jan 9. doi: 10.1038/s41591-022-02097.
    PubMed     Abstract available


    September 2022
  6. IANIRO G, Puncochar M, Karcher N, Porcari S, et al
    Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Nat Med. 2022;28:1913-1923.
    PubMed     Abstract available


  7. OKANO H
    A combined stem-cell-gene therapy strategy for ALS.
    Nat Med. 2022;28:1751-1752.
    PubMed    


  8. BALOH RH, Johnson JP, Avalos P, Allred P, et al
    Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1/2a trial.
    Nat Med. 2022;28:1813-1822.
    PubMed     Abstract available


    July 2022
  9. ROBERTSON NA, Latorre-Crespo E, Terradas-Terradas M, Lemos-Portela J, et al
    Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects.
    Nat Med. 2022;28:1439-1446.
    PubMed     Abstract available


    April 2022
  10. GANAN-GOMEZ I, Yang H, Ma F, Montalban-Bravo G, et al
    Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
    Nat Med. 2022 Apr 28. pii: 10.1038/s41591-022-01827.
    PubMed    



  11. A distinct hematopoietic differentiation state characterizes aggressive infant leukemia.
    Nat Med. 2022;28:641-642.
    PubMed    


    March 2022
  12. GANAN-GOMEZ I, Yang H, Ma F, Montalban-Bravo G, et al
    Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy.
    Nat Med. 2022 Mar 3. pii: 10.1038/s41591-022-01696.
    PubMed     Abstract available


    February 2022

  13. Bone marrow transplantation chemotherapy disrupts regenerative brain cell populations.
    Nat Med. 2022 Feb 24. pii: 10.1038/s41591-022-01722.
    PubMed    


  14. SAILOR KA, Agoranos G, Lopez-Manzaneda S, Tada S, et al
    Hematopoietic stem cell transplantation chemotherapy causes microglia senescence and peripheral macrophage engraftment in the brain.
    Nat Med. 2022 Feb 21. pii: 10.1038/s41591-022-01691.
    PubMed     Abstract available


  15. DU Y, Liang Z, Wang S, Sun D, et al
    Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates.
    Nat Med. 2022 Feb 3. pii: 10.1038/s41591-021-01645.
    PubMed     Abstract available


    November 2021
  16. PHILIPPI A, Heller S, Costa IG, Senee V, et al
    Mutations and variants of ONECUT1 in diabetes.
    Nat Med. 2021;27:1928-1940.
    PubMed     Abstract available


  17. NIROULA A, Sekar A, Murakami MA, Trinder M, et al
    Distinction of lymphoid and myeloid clonal hematopoiesis.
    Nat Med. 2021;27:1921-1927.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: